skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,506  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial

The lancet oncology, 2013-08, Vol.14 (9), p.823-833 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 2013 ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(13)70274-2 ;PMID: 23850491 ;CODEN: LANCAO

Full text available

2
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
Material Type:
Article
Add to My Research

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial

Clinical infectious diseases, 2022-09, Vol.75 (4), p.690-701 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciab988 ;PMID: 34864943

Full text available

3
Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection
Material Type:
Article
Add to My Research

Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection

Transplantation, 2016-10, Vol.100 (10), p.e74 [Peer Reviewed Journal]

EISSN: 1534-6080 ;DOI: 10.1097/TP.0000000000001418 ;PMID: 27495775

Digital Resources/Online E-Resources

4
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Material Type:
Article
Add to My Research

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

Cochrane database of systematic reviews, 2008-01 (2), p.CD003774 [Peer Reviewed Journal]

EISSN: 1469-493X ;DOI: 10.1002/14651858.CD003774.pub3 ;PMID: 18425894

Full text available

5
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial
Material Type:
Article
Add to My Research

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial

International journal of cancer, 2019-09, Vol.145 (6), p.1538 [Peer Reviewed Journal]

2019 UICC. ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.32230 ;PMID: 30801698

Digital Resources/Online E-Resources

6
Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial
Material Type:
Article
Add to My Research

Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial

Clinical infectious diseases, 2022-03, Vol.74 (5), p.757-765 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciab574 ;PMID: 34228099

Full text available

7
CMV: Prevention, Diagnosis and Therapy
Material Type:
Article
Add to My Research

CMV: Prevention, Diagnosis and Therapy

American journal of transplantation, 2013-02, Vol.13 (s3), p.24-40 [Peer Reviewed Journal]

Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons ;Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons. ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.12006 ;PMID: 23347212

Full text available

8
Filociclovir is a potent inhibitor of human adenovirus F41
Material Type:
Article
Add to My Research

Filociclovir is a potent inhibitor of human adenovirus F41

Antiviral research, 2022-12, Vol.208, p.105431 [Peer Reviewed Journal]

Copyright © 2022 Elsevier B.V. All rights reserved. ;EISSN: 1872-9096 ;DOI: 10.1016/j.antiviral.2022.105431 ;PMID: 36209985

Digital Resources/Online E-Resources

9
A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19
Material Type:
Article
Add to My Research

A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19

Antiviral research, 2020-08, Vol.180, p.104857 [Peer Reviewed Journal]

Copyright © 2020 Elsevier B.V. All rights reserved. ;EISSN: 1872-9096 ;DOI: 10.1016/j.antiviral.2020.104857 ;PMID: 32562705

Digital Resources/Online E-Resources

10
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients
Material Type:
Article
Add to My Research

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients

The Journal of infectious diseases, 2024-02, Vol.229 (2), p.413-421 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2023 ;The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiad293 ;PMID: 37506264

Full text available

11
Activation of the STING-Dependent Type I Interferon Response Reduces Microglial Reactivity and Neuroinflammation
Material Type:
Article
Add to My Research

Activation of the STING-Dependent Type I Interferon Response Reduces Microglial Reactivity and Neuroinflammation

Neuron (Cambridge, Mass.), 2017-12, Vol.96 (6), p.1290-1302.e6 [Peer Reviewed Journal]

2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 20, 2017 ;ISSN: 0896-6273 ;EISSN: 1097-4199 ;DOI: 10.1016/j.neuron.2017.11.032 ;PMID: 29268096

Full text available

12
Survival in Patients with Glioblastoma Receiving Valganciclovir
Material Type:
Article
Add to My Research

Survival in Patients with Glioblastoma Receiving Valganciclovir

The New England journal of medicine, 2013-09, Vol.369 (10), p.985-986 [Peer Reviewed Journal]

Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc1302145 ;PMID: 24004141

Full text available

13
How I treat T-cell chronic active Epstein-Barr virus disease
Material Type:
Article
Add to My Research

How I treat T-cell chronic active Epstein-Barr virus disease

Blood, 2018-06, Vol.131 (26), p.2899-2905 [Peer Reviewed Journal]

2018 American Society of Hematology ;2018 by The American Society of Hematology. ;2018 by The American Society of Hematology 2018 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-03-785931 ;PMID: 29712633

Full text available

14
Cytomegalovirus after kidney transplantation in 2020: moving towards personalized prevention
Material Type:
Article
Add to My Research

Cytomegalovirus after kidney transplantation in 2020: moving towards personalized prevention

Nephrology, dialysis, transplantation, 2022-04, Vol.37 (5), p.810-816 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the ERA-EDTA. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the ERA-EDTA. ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfaa249 ;PMID: 33280028

Full text available

15
The Best Method for CMV Prevention in High-risk Kidney Transplant Recipients? Either, per National Norwegian Transplant Database: Commentary on Blom et al, Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
Material Type:
Article
Add to My Research

The Best Method for CMV Prevention in High-risk Kidney Transplant Recipients? Either, per National Norwegian Transplant Database: Commentary on Blom et al, Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management

Transplantation, 2023-08, Vol.107 (8), p.1671 [Peer Reviewed Journal]

EISSN: 1534-6080 ;DOI: 10.1097/TP.0000000000004616 ;PMID: 37211634

Digital Resources/Online E-Resources

16
Antiviral Drug Resistance of Human Cytomegalovirus
Material Type:
Article
Add to My Research

Antiviral Drug Resistance of Human Cytomegalovirus

Clinical Microbiology Reviews, 2010-10, Vol.23 (4), p.689-712 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright © 2010, American Society for Microbiology 2010 ;ISSN: 0893-8512 ;EISSN: 1098-6618 ;DOI: 10.1128/CMR.00009-10 ;PMID: 20930070 ;CODEN: CMIREX

Full text available

17
Emergence of letermovir resistance in a lung transplant recipient with ganciclovir‐resistant cytomegalovirus infection
Material Type:
Article
Add to My Research

Emergence of letermovir resistance in a lung transplant recipient with ganciclovir‐resistant cytomegalovirus infection

American journal of transplantation, 2018-12, Vol.18 (12), p.3060-3064 [Peer Reviewed Journal]

2018 The American Society of Transplantation and the American Society of Transplant Surgeons ;2018 The American Society of Transplantation and the American Society of Transplant Surgeons. ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.15135 ;PMID: 30286286

Full text available

18
Cell and Tissue Specific Metabolism of Nucleoside and Nucleotide Drugs: Case Studies and Implications for Precision Medicine
Material Type:
Article
Add to My Research

Cell and Tissue Specific Metabolism of Nucleoside and Nucleotide Drugs: Case Studies and Implications for Precision Medicine

Drug metabolism and disposition, 2023-03, Vol.51 (3), p.360-368 [Peer Reviewed Journal]

Copyright © 2023 by The American Society for Pharmacology and Experimental Therapeutics. ;ISSN: 0090-9556 ;EISSN: 1521-009X ;DOI: 10.1124/dmd.122.000856 ;PMID: 36446610

Full text available

19
Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads
Material Type:
Article
Add to My Research

Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads

Journal of antimicrobial chemotherapy, 2022-02, Vol.77 (2), p.466-473 [Peer Reviewed Journal]

The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. ;ISSN: 0305-7453 ;EISSN: 1460-2091 ;DOI: 10.1093/jac/dkab419 ;PMID: 35107143

Full text available

20
Cytomegalovirus infection in transplant recipients: newly approved additions to our armamentarium
Material Type:
Article
Add to My Research

Cytomegalovirus infection in transplant recipients: newly approved additions to our armamentarium

Clinical microbiology and infection, 2023-01, Vol.29 (1), p.44-50 [Peer Reviewed Journal]

2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved. ;ISSN: 1198-743X ;EISSN: 1469-0691 ;DOI: 10.1016/j.cmi.2022.07.001 ;PMID: 35843567

Digital Resources/Online E-Resources

Results 1 - 20 of 3,506  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1995  (521)
  2. 1995 To 2001  (1,146)
  3. 2002 To 2008  (795)
  4. 2009 To 2016  (742)
  5. After 2016  (303)
  6. More options open sub menu

Language 

  1. English  (3,203)
  2. Japanese  (403)
  3. Spanish  (68)
  4. French  (65)
  5. Chinese  (50)
  6. German  (31)
  7. Polish  (11)
  8. Portuguese  (10)
  9. Italian  (8)
  10. Russian  (7)
  11. Norwegian  (4)
  12. Korean  (3)
  13. Swedish  (3)
  14. Danish  (3)
  15. Lithuanian  (2)
  16. Hungarian  (2)
  17. Dutch  (2)
  18. Czech  (1)
  19. Estonian  (1)
  20. Finnish  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait